The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
CORONARY INTERVENTIONS
Is quantitative coronary angiography reliable in assessing the lumen gain after treatment with the everolimus-eluting bioresorbable polylactide scaffold?
EuroIntervention 2016;12:e998-e1008 published online e-edition October 2016. DOI: 10.4244/EIJV12I8A163
Yohei Sotomi1, MD; Yoshinobu Onuma2,3, MD, PhD; Pannipa Suwannasom1,2,4, MD; Hiroki Tateishi2, MD, PhD; Erhan Tenekecioglu2, MD; Yaping Zeng2, MD, PhD; Rafael Cavalcante2, MD, PhD; Hans Jonker3, BSc; Jouke Dijkstra5, PhD; Nicolas Foin6, MSc, PhD; Jaryl Ng Chen Koon6, B.Eng; Carlos Collet1, MD; Robbert J. de Winter1, MD, PhD; Joanna J. Wykrzykowska1, MD, PhD; Gregg W. Stone7, MD; Jeffrey J. Popma8, MD, PhD; Ken Kozuma9, MD, PhD; Kengo Tanabe10, MD, PhD; Pat
1. Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; 2. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 3. Cardialysis, Rotterdam, The Netherlands; 4. Northern Region Heart Center, Faculty of Medicine, Chiang
Aims: The current study aimed to assess the difference in lumen dimension measurements between optical coherence tomography (OCT) and quantitative coronary angiography (QCA) in the polyme